IOI Oleo GmbH’s Post

How does your manufacturing partner differentiate themselves? Learn more about the #customer- and #patient-centric approach of #Aenova which ensures that we focus on delivering exceptional #quality and results. Mara Candido explains how #Aenova Group supports your #manufacturing projects. #CPHIBCN #pharma #CDMO https://lnkd.in/emwBFCV7

Field sales are not just about selling products—they are about building relationships, gathering insights, and ensuring that innovative healthcare solutions reach those who need them. Pharmaceutical companies that invest in effective field sales teams position themselves for growth, impact, and long-term success. 🚀 ☀️ Last week, our field sales team gathered for their summer conference in Bayreuth. 💬 The days were filled with updates on products as well as group discussions to dive deeper into various topics and regions. During the shared dinners and subsequent soccer viewing, there were many opportunities for further exchange. The conference was a resounding success - an informative gathering that strengthened professional bonds and underscored the pivotal role of field sales. 🙌🏼 #WörwagPharma #GettingCloser #HelpingBetter #SalesConference #Networking

Have you seen our #FlyPharma Europe 2023 video yet? Relive the event and view all the highlights of our Vienna conference this year. You can watch the video on our website here: https://lnkd.in/emCgiHYh #vienna #pharma #supplychain #logistics #networking #conference

Thoughts on this? >> J&J cements footprint in Italy with €580M in investments over the next 5 years >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #healthcare #pharmaceutical

The first investment refers to INDUSTRY 5.0 approved by the European Commission. Company #Vonpharma Si, predstavništvo in prodaja, d. o. o. Location #SLOVENIA Amount EUR 5,870,871.27. The company and the products or services are in no relation to INDUSTRY 5.0 origin or principles. Details zn the next INDUSTRY 5.0 NEWSLETTER INDUSTRY 5.0 AMBASSADORS NETWORK Industry 5.0 INDUSTRY 5.0 STRATEGIC ALLIANCE

#EVOKUpdates - Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI "Halfway into 2024, as prescriptions continue to grow, we are executing on our distribution expansion strategy and are seeing improved growth trajectory of access and sales for GIMOTI. The combination of the shift to ASPN and the expansion of additional regional pharmacies is yielding results to help unlock GIMOTI's true market potential," stated Matt D'Onofrio, Chief Executive Officer of Evoke Pharma. Please view the full announcement here: https://lnkd.in/eMw8wMTn. #EVOK #gastroparesis #GIMOTI

Great to have you at euroPLX 85 Dublin Ádám Szabó, Gábor Bajúsz, Gabriella Lung-Molnár and Goodwill Pharma. #europlx #raucon #businessdevelopment #business #development #event #sales #events #tips #tip #partnering #success #pro #networking #network #pharma #pharmaceutical #opportunities #businessopportunities #networkingevent #benchmark

Thoughts on this? >> J&J cements footprint in Italy with €580M in investments over the next 5 years >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #healthcare #biotech

We are excited about what is to come in 2024, and we are nearly ready to launch our next #FlyPharma conference! Stay tuned - and while you wait here is a throwback to FlyPharma Europe 2023 in Vienna... Watch our interview with Harald Lassmann from Lassmann Pharma Logistics below, or on our website, here: https://lnkd.in/esBfKrKy #pharma #conference #vienna #supplychain #logistics

#PRESS: CEO COMMENT ON NOMINATION TO BECOME NEXT CHAIRMAN - “Given the path lying ahead of PILA PHARMA, I have recently evaluated that I will best serve the Shareholders of PILA PHARMA by becoming the Company’s next Chairman of the Board. At the General Meeting on 18 April 2024, I hope to get the shareholders support for this move and the underlying plan of recalibrating PILA PHARMA for future success. Should I get the support from our shareholders and become the next Chairman of the Board in PILA PHARMA, I will immediately step down as CEO and the company will work to find a new CEO who can secure the company’s future success. Some have told me that I’m the identity of PILA PHARMA and I believe that’s true. But for me PILA PHARMA is also my identity! So, there should be no doubt that I will keep working relentlessly for our Company’s success – and from April hopefully as working Chairman in a strong partnership with a new CEO.“ https://lnkd.in/e7GtXndZ